In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
- PMID: 14704432
- DOI: 10.1126/science.1092472
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2
Abstract
MDM2 binds the p53 tumor suppressor protein with high affinity and negatively modulates its transcriptional activity and stability. Overexpression of MDM2, found in many human tumors, effectively impairs p53 function. Inhibition of MDM2-p53 interaction can stabilize p53 and may offer a novel strategy for cancer therapy. Here, we identify potent and selective small-molecule antagonists of MDM2 and confirm their mode of action through the crystal structures of complexes. These compounds bind MDM2 in the p53-binding pocket and activate the p53 pathway in cancer cells, leading to cell cycle arrest, apoptosis, and growth inhibition of human tumor xenografts in nude mice.
Similar articles
-
Small-molecule antagonists of p53-MDM2 binding: research tools and potential therapeutics.Cell Cycle. 2004 Apr;3(4):419-21. Epub 2004 Apr 1. Cell Cycle. 2004. PMID: 15004525
-
Cancer research. Drug candidate bolsters cell's tumor defenses.Science. 2004 Jan 2;303(5654):23-5. doi: 10.1126/science.303.5654.23a. Science. 2004. PMID: 14704399 No abstract available.
-
Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.Int J Oncol. 2013 Dec;43(6):1935-42. doi: 10.3892/ijo.2013.2138. Epub 2013 Oct 14. Int J Oncol. 2013. PMID: 24126697
-
Small-molecule inhibitors of the p53-MDM2 interaction.Curr Top Microbiol Immunol. 2011;348:151-72. doi: 10.1007/82_2010_110. Curr Top Microbiol Immunol. 2011. PMID: 21046355 Review.
-
Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy.Annu Rev Pharmacol Toxicol. 2009;49:223-41. doi: 10.1146/annurev.pharmtox.48.113006.094723. Annu Rev Pharmacol Toxicol. 2009. PMID: 18834305 Free PMC article. Review.
Cited by
-
KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300.Int J Biol Sci. 2024 Sep 23;20(13):5127-5144. doi: 10.7150/ijbs.98668. eCollection 2024. Int J Biol Sci. 2024. PMID: 39430242 Free PMC article.
-
Ubiquitin-proteasome system and the role of its inhibitors in cancer therapy.Open Biol. 2021 Apr;11(4):200390. doi: 10.1098/rsob.200390. Epub 2021 Apr 28. Open Biol. 2021. PMID: 33906413 Free PMC article.
-
The E3 ubiquitin ligase mind bomb 1 ubiquitinates and promotes the degradation of survival of motor neuron protein.Mol Biol Cell. 2013 Jun;24(12):1863-71. doi: 10.1091/mbc.E13-01-0042. Epub 2013 Apr 24. Mol Biol Cell. 2013. PMID: 23615451 Free PMC article.
-
p53 is required for brown adipogenic differentiation and has a protective role against diet-induced obesity.Cell Death Differ. 2013 May;20(5):774-83. doi: 10.1038/cdd.2013.9. Epub 2013 Feb 15. Cell Death Differ. 2013. PMID: 23412343 Free PMC article.
-
Senescence sensitivity of breast cancer cells is defined by positive feedback loop between CIP2A and E2F1.Cancer Discov. 2013 Feb;3(2):182-97. doi: 10.1158/2159-8290.CD-12-0292. Epub 2013 Jan 10. Cancer Discov. 2013. PMID: 23306062 Free PMC article.
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous